Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > NDA approval

<< Previous

Bullboard Posts

Next >>

Comment by Redwine12345on May 27, 2024 2:29pm

76 Views

Post# 36059188

RE:RE:RE:RE:RE:RE:RE:RE:NDA approval

Before buying back shares, the company should get a positive cash flow. Once you get a positive cash flow, the company should evaluate all investment opportunities. If they can't find suitable return, then distribution of cash could be done via dividend or share buyback.

Sorry man, it is a wishful thinking on your part.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023